Alnylam Pharmaceuticals, Inc. (LON: 0HD2)
London
· Delayed Price · Currency is GBP · Price in USD
244.03
0.00 (0.00%)
At close: Dec 23, 2024
Alnylam Pharmaceuticals Employees
Alnylam Pharmaceuticals had 2,100 employees as of December 30, 2023. The number of employees increased by 98 or 4.90% compared to the previous year.
Employees
2,100
Change (1Y)
98
Growth (1Y)
4.90%
Revenue / Employee
744.25K GBP
Profits / Employee
-118.05K GBP
Market Cap
25.18B
Employees Chart
Employees History
Alnylam Pharmaceuticals News
- 13 days ago - $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Benzinga
- 26 days ago - Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 27 days ago - Check Out What Whales Are Doing With ALNY - Benzinga
- 4 weeks ago - Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy - Business Wire
- 5 weeks ago - Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose - Business Wire
- 7 weeks ago - Alnylam to Webcast Presentations at Upcoming November Investor Conferences - Business Wire
- 7 weeks ago - Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity - Business Wire